In our previous paper2), the synthesis and antibacterial activity of 3-[2-(2-aminothiazol-4-yl)-(Z)-2-(substituted oxyimino)acetamido]-4-methoxycarbonyl-2-azetidinonel -sulfonic acids (1) were reported; it was demonstrated that introducing a methoxycarbonyl group at the 4-position of sulfazecintype derivatives, especially in 3,4-cis configuration, significantly enhanced antibacterial activity against Gram-negative bacteria including S-lactamase producing strains. These findings prompted us to synthesize a number of 1-sulfo-2-azetidinones having various kinds of substituents at the 4-position for further improvement of the antibacterial activity. In this paper, the synthesis and antibacterial activity of 4-(substituted methyl)-2-azetidinone-l-sulfonic acid derivatives (2) including AMA-1080 (3)1), a clinical candidate of this series, will be reported. 
t Part of this paper was reported as a communication1) .
via the 4-hydroxymethyl compounds (7, 8 and their traps isomers), which were the key intermediates for the chemical modification in this study (Chart 2). Protection of the 3-amino group of compound 4 gave 3-benzyloxycarbonylamino and 3-(2,2,2-trichloroethoxycarbonylamino) derivatives (5-A2) and 5-B), and subsequent oxidative cleavage3~ of the 2,4-dimethoxybenzyl group using potassium persulfate afforded the corresponding 1-unsubstituted-2-azetidinones (6-A2) and 6-B), respectively. Reduction3) of the 4-methoxycarbonyl groups of 5 and 6 with sodium borohydride gave the cis-4-hydroxymethyl compounds (7 and 8) . give the 4-acylaminomethyl (9g,h,i-A) and 4-carbamoylaminomethyl (9j-A) derivatives, respectively. Removal of the 2,4-dimethoxybenzyl groups from these compounds afforded 10g,h,i,j-A. In the meanwhile, mesylation of 7 and 8 gave the 4-mesyloxymethyl compounds (9f and 10f), which were then transformed into the 4-chloromethyl (10k) and 4-iodomethyl (9m and l0m) derivatives. The iodomethyl groups of 9m and l0m were further converted into various 4-substituents; treatment of the iodides with thiols, sodium azide, and potassium cyanide gave the 4-thiomethyl (l0n,p-B), 4-azidomethyl (10q-C)* and 4-cyanomethyl (9r-A) compounds, respectively. Compound 9r-A was converted into the 1-unsubstituted derivative (l0r-A) by persulfate oxidation.
Two 3,4-traps analogues (13a,d-A) were prepared from 12 in a similar manner to that described for the synthesis of the corresponding 3,4-cis isomers.
Deprotection of 10 and subsequent acylation with 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride5) gave the 3-acylamino compounds (14), which were converted into sodium
nates (16) by sulfonation6,7) with sulfur trioxide-pyridine complex (SO3 • Pyridine) and removal5) of the * In the case of the 4-azidomethyl compound , 2-methylsulfonylethoxycarbonyl group was adopted to protect the 3-amino moiety, because azides are unstable to the reaction conditions used for deprotection of the above two protecting groups. The traps isomer (17)* of the 4-acetoxymethyl compound (16a) was similarly prepared from 13a-A.
The in vitro antibacterial activity of 16 and 17 is shown in Table 1 . These 4-(substituted methyl)-1-sulfo-2-azetidinones, as well as the corresponding 4-methoxycarbonyl compounds=, generally showed good antibacterial activity against Gram-negative bacteria and improved activity against Escherichia coil T-7, a producer of the TEM-1 /3-lactamase, as compared with the corresponding 4-unsubstituted derivative''.
However, the potency of the activity varies with the size or lipophilicity of the 4-substituent and tends to decrease when an aromatic ring is introduced as a part of the substituent (compare the activity of 16a, 16h and 16n with that of 16b, 16i and 16p, respectively). Carbamoyloxymethyl, acetoxymethyl, acetamidomethyl and azidomethyl groups were efficient substituents in this series. The cis-4-acetoxymethyl compound (16a) was more active than the corresponding trans isomer (17) in analogy with the cases of 4-methoxycarbonyl2) and 4-methyl9) derivatives.
Selection of the 3-Acyl Group
In order to examine the effect of the 3-acyl moiety on the antibacterial activity of 4-(substituted methyl)-2-azetidinone-l-sulfonic acids (2), the acyl moiety of ceftazidime and an analogous group were * The (3S ,4R)-and (3R,45)-enantiomers of this compound were independently synthesized by SHIBUYA et al.8) introduced at the 3-position*. Carbamoyloxymethyl, acetoxymethyl and acetamidomethyl groups were selected as representative 4-substituents in this study, and some related groups were also investigated for further improvement of the activity (Chart 4). Deprotection of 10 and subsequent acylation As shown in Table 2 , some of these compounds (22 25) showed good to excellent antibacterial activity against Gram-negative bacteria including Pseudomonas aeruginosa. Among four compounds bearing a carbamoyloxymethyl group, the most efficient 4-substituent found in the present study, and (3R,4R)-23d, respectively, by acylation and subsequent deprotection.
As shown in Table 3 , the (3S,4S)-isomer (3, AMA-1080) was found to be far more active than the corresponding (3R,4R)-enantiomer83, and showed not only potent antibacterial activity against Gramnegative bacteria but also good protective effect on experimental intraperitoneal infection in micelle.
Compound 3 was also highly resistant to hydrolysis by various types of ,3-lactamases including those produced by Klebsiella pneumoniae, Proteus vulgaris and Bacteroides fragilis which hydrolyzed aztreonam and several newer cephalosporins12). Investigations on the practical method for the production of AMA-1080 (Ro 17-2301) and its clinical trial are now in progress.
Experimental
Melting points were determined using a Yanagimoto melting point apparatus and are uncorrected. IR spectra were measured with a Hitachi 215 spectrometer. 1H NMR spectra were taken on a Varian T-60 (60 MHz) or a Varian EM-390 (90 MHz) spectrometer using TMS as an internal standard. Chemical shifts in the NMR spectra are given with proton numbers, absorption patterns, and coupling constants (Hz) in parentheses. Abbreviations are as follows: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; q, quartet; ABq, AB quartet; m, multiplet; br, broad. Extracted solutions were dried over sodium sulfate or magnesium sulfate.
A solution of 2,2,2-trichloroethyl chloroformate (1.27 g, 6 mmol) in CH2C12 (1 ml) was added dropwise to a stirred, cooled (0°C) mixture of cis-3-amino-l-(2,4-dimethoxybenzyl)-4-methoxycarbonyl-2-azetidinone (4)2) (1.18 g, 4 mmol) and propylene oxide (2.7 ml) in CH2CI2 (5 ml) over 10 minutes, and the mixture was stirred for 30 minutes at room temp. The mixture was concentrated under reduced pressure and the solid residue was washed with ether to give 5-B (1.67 g, 89 %) as colorless crystals. 
Compound 7-B was prepared from 5-B by a method similar to that described above. cis-3-Benzyloxycarbonylamino-4-hydroxymethyl-2-azetidinone (8-A) A solution of sodium borohydride (189 mg, 5 mmol) in water (1.3 ml) was added to a stirred solution of cis-3-benzyloxycarbonylamino-4-methoxycarbonyl-2-azetidinone (6-A)2'13 ' (557 mg, 2 mmol) in THE (2.6 ml) at 0 -' 5°C, and the mixture was stirred for 80 minutes at the same temp. After the excess sodium borohydride had been decomposed with ACOH, the reaction mixture was concentrated under reduced pressure. The concentrate was diluted with brine and extracted with EtOAc. The extract was dried and concentrated under reduced pressure. The residue was chromatographed on silica gel with EtOAc -acetonitrile cis-4-Acetoxymethyl-3-benzyloxycarbonylamino-2-azetidinone (lOa-A) and Its trans Isomer (13a-A) (a) Acetyl chloride (2.25 g, 28.7 mmol) was added dropwise to a mixture of 7-A (5.1 g, 12.7 mmol) and pyridine (3.8 ml) in CH.,C1.: (50 ml) at 0 ti 5°C, and the mixture was stirred for 30 minutes at the same temp. After concentration under reduced pressure, the residue was chromatographed on silica gel with EtOAc to give cis-4-acetoxymethyl-3-benzyloxycarbonylamino-l-(2,4-dimethoxvbenzyl)-2-azetidinone (9a-A) ( cis-3-Benzyloxycarbonylamino-4-carbamoyloxymethyl-2-azetidinone (lOd-A) and Its trans Isomer (13d-A) (a) Chlorosulfonyl isocyanate (0.09 ml, 1 mmol) was added to an ice-cooled solution of 7-A (400 mg, 1 mmol) in CH2C12 (8 ml) with stirring, and the mixture was stirred for 30 minutes under icecooling. After further addition of chlorosulfonyl isocyanate (0.09 ml), the mixture was stirred for 10 minutes at the same temp. A solution of sodium sulfite (280 mg) in water (6 ml) was added, and the mixture was stirred for 1 hour at room temp and diluted with CH2C12. The organic layer was separated, washed with brine, dried and concentrated under reduced pressure. The residue was triturated with ether, and the resulting crystals were collected by filtration to give cis-3-benzyloxycarbonylamino-4-carbamoyloxymethyl-l-(2,4-dimethoxybenzyl)-2-azetidinone (9d-A) (330 mg, 74%) as colorless crystals. cis-3-Benzyloxycarbonylamino-4-mesyloxymethyl-2-azetidinone (lOf-A) (a) Mesyl chloride (5.15 g, 45 mmol) was added dropwise to an ice-cooled solution of 7-A (12.0 g, 30 mmol) in pyridine (90 ml). After being stirred for 1 hour at room temp, the reaction mixture was diluted with water (150 ml), THE (150 ml) and EtOAc (150 ml), and adjusted to pH 2 with 6 N HCI. After separation of the organic layer, the aqueous layer was extracted with a mixture of EtOAc -THE (2: 1). The combined extracts were washed successively with water, aq NaHCO3 and brine, dried, and evaporated to dryness. The solid residue was washed with ether to give cis-3-benzyloxycarbonylamino-1-(2,4-dimethoxybenzyl)-4-mesyloxymethyl-2-azetidinone (9f-A) (13.7 g, 96%) as colorless crystals. cis-4-Mesyloxymethyl-3-(2-methylsulfonylethoxycarbonylamino)-2-azetidinone (lOf-C) A suspension of l0f-A (3.28 g, 10 mmol) and 5 % Pd-C (3.28 g) in EtOH (100 ml) was stirred for 50 minutes at room temp under a hydrogen atmosphere. The catalyst was filtered off and the filtrate was concentrated, and the residue was dissolved in a mixture of CH2C12 (100 ml) and N,N-dimethylacetamide (15 ml). After addition of propylene oxide (6.99 ml), a solution of 2-methylsulfonylethyl chloroformate (2.79 g) in CHQC12 (25 ml) was added dropwise to the ice-cooled solution with stirring, and the mixture was stirred for 2 hours at room temp. After removal of the solvent, the residue was dissolved in a mixture of THE -EtOAc (1: 1) and brine, and the organic layer was separated, dried and concentrated cis-3-Benzyloxycarbonylamino-l-(2,4-dimethoxybenzyl)-4-phthalimidomethyl-2-azetidinone (11-A) Diethyl azodicarboxylate (0.47 ml, 3 mmol) was added to a stirred mixture of 7-A (1.0 g, 2.5 mmol), triphenylphosphine (787 mg, 3 mmol) and phthalimide (441 mg, 3 mmol) in THE (20 ml), and the mixture was stirred for 1 hour at room temp. After evaporation of the solvent, the solid residue was washed with EtOAc to give 11-A (1.16 g, 88%) (1H, d, 9 ).
cis-3-Benzyloxycarbonylamino-4-formylaminomethyl-2-azetidinone (l0g-A) Hydrazine hydrate (3.10 g, 61.2 mmol) was added to a suspension of 11-A (3.55 g, 6.72 mmol) in EtOH (200 ml), and the mixture was refluxed for 2.5 hours and cooled to 0-5°C.
The resulting precipitate was filtered off and the filtrate was concentrated under reduced pressure. The residue was dissolved in CH,C1,, and the solution was washed with water, dried and evaporated to dryness to give the 4-aminomethyl compound as a solid. A mixture of formic acid (4 ml) and acetic anhydride (4 ml) was stirred for 30 minutes at 60°C and allowed to come to room temp. The reaction mixture was added to the solid (the 4-aminomethyl compound) obained above, and the whole mixture was stirred for 2 hours at room temp. The mixture was diluted with EtOAc, washed successively with water, aq NaHCO3 and brine, dried, and concentrated under reduced pressure to give cis-3-benzyloxycarbonylamino-l-(2,4-dimethoxybenzyl)-4-formylaminomethyl-2-azetidinone (9g-A) as a foam, which was used in the subsequent reaction without further purification. According to the general procedure I, the 2,4-dimethoxybenzyl group of 9g-A was removed to give l0g-A (367 mg, 20%) as a foam. IR vmax cm-1 1760. NMR (DMSO-dg) o 3. cis-4-Acetamidomethyl-3-benzyloxycarbonylamino-2-azetidinone (lOh-A) (a) The 4-aminomethyl compound, which was prepared from 11-A (1.059 g, 2 mmol) by the same method as described above, was dissolved in a mixture of CH2C12 (10 ml) and N,N-dimethylacetamide (5 ml), and propylene oxide (1.4 ml) and acetyl chloride (0.28 ml, 4 mmol) were added to the stirred solution under ice-cooling. After being stirred for 1 hour at room temp, the reaction mixture was diluted with CH2C12 (100 ml) and aq NaHC03 (50 ml). The organic layer was separated, washed successively with water, dil HCl and brine, dried, and concentrated under reduced pressure. The residue was chromatographed on silica gel with CHC13 -acetonitrile cis-3-Benzyloxycarbonylamino-4-chloromethyl-2-azetidinone (10k-A) A solution of 10f-A (657 mg, 2 mmol) in DMF (2.6 ml) was added to a solution of lithium chloride (861 mg, 20.3 mmol) in DMF (7.8 ml). The mixture was stirred for 3 hours at 73°C under an argon atmosphere, allowed to come to room temp, poured into brine (60 ml), and extracted with EtOAc. The extract was washed with brine, dried and concentrated under reduced pressure. The residue was chromatographed on silica gel with EtOAc -hexane cis-4-(1-Methyl-1 H-tetrazol-5-yl)thiomethyl-3-(2, 2, 2-trichloroethoxycarbonylamino)-2-azetidinone (10p-B) Sodium hydride (65 mg, 2.71 mmol) was added to a stirred, cooled (0°C) solution of 5-mercapto-lmethyl-lH-tetrazole (314 mg, 2.71 mmol) in DMF (2 ml), and the mixture was stirred for 10 minutes under ice-cooling and 10 minutes at room temp. To the mixture was added a solution of 10m-B (724 mg, 1.8 mmol) in DMF (3 ml). After being stirred for 2 days at room temp, the reaction mixture was diluted with EtOAc, washed successively with water and brine, dried and concentrated under reduced pressure. The residue was chromatographed on silica gel with EtOAc -hexane (4: 1) to give 10p-B (610 mg, 87%) as crystals. MP 67-69°C.
IR vmB; cm-1 1740. NMR (CDC13) S 3. (500 mg) in EtOH (50 ml) was stirred for 30 minutes at room temp under a hydrogen atmosphere. The catalyst was filtered off and the filtrate was concentrated under reduced pressure. The residue was dissolved in a mixture of THE (15 ml) and water (15 ml). To the ice-cooled solution were added NaHCO3 (1.05 g, 12.5 mmol) and 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride (CATAM-Cl • HCl)5) (2.0 g, 6 mmol) with stirring. After being stirred for 1 hour under ice-cooling, the resulting precipitate was collected by filtration and washed successively with aq NaHCO3, water and ether to give 14a (1.86 g, 89%) as colorless crystals.
Compounds 14b,d,f,h,i,k and trans isomer of 14a were similarly synthesized and the results are shown in Table 4 .
Method B : Procedure Starting from 10-B: Zinc (5.5 g) and 1 M KHPO4 (11 ml) were added to a stirred solution of 10n-B (643 mg, 2 mmol) in THE (55 ml), and the mixture was stirred for 2 hours at room temp. The zinc was removed by filtration and the filtrate was concentrated under reduced pressure. The concentrate was dissolved in a mixture of THE (20 ml) and water (20 ml). To the stirred, cooled (0°C) solution were added NaHCO3 (588 mg, 7 mmol) and CATAM-Cl • HCl (998 mg, 3 mmol), and the mixture was stirred for 30 minutes under ice-cooling, and diluted with EtOAc. The organic layer was separated, washed with brine, dried and evaporated to dryness. The solid residue was washed with EtOAc -ether (1: 2) to give 14n (591 mg, 73%) as colorless crystals.
Compounds 14c,p were similarly synthesized and the results are shown in Table 4 . Method C : Procedure Starting from 10-C: Sodium hydroxide (11.4 ml of 0.5 N EtOH solution, 5.7 mmol) was added to an ice-cooled solution of 10q-C (757 mg, 2.6 mmol) in a mixture of EtOH (60 ml) and DIM (6 ml), and the mixture was stirred for 40 minutes under ice-cooling. After addition of 1 N HCl (5.7 ml), the mixture was concentrated under reduced pressure. The residue was dissolved in a mixture of water (15 ml) and THE (15 ml). To the ice-cooled solution were added NaHCO3 (874 mg, 10.4 mmol) and CATAM-C1. HC1(1.297 g, 3.9 mmol), and the mixture was stirred for 40 minutes under ice-cooling. The reaction mixture was diluted with water and extracted with EtOAc. The extract was washed with water and brine, dried and evaporated to dryness. The solid residue was washed with EtOAc and ether to give 14q (679 mg, 65 %) as colorless crystals. The physical data of 14q are shown in Table 4 . General Procedure II: Sulfonation at the 1-Position: To a stirred solution of 14 (1 mmol) in DMF (5 10 ml) was added S03 • Pyridine (318 mg, 2 mmol), and the mixture was stirred for 48 hours at room temp. After further addition of S03 • Pyridine (159 mg, 1 mmol), the mixture was stirred for 24 hours. Ether (50-100 ml) was added, and the resulting precipitate was collected by decantation (or filtration) and washed with ether. The precipitate was dissolved (or suspended) in water and treated with Dowex SOW (Na+) for 1 hour at room temp. After removal of the resin by filtration, the filtrate was concentrated under reduced pressure. The concentrate was chromatographed on Amberlite XAD-2. Gradient elution with aq EtOH (0 20%) and lyophilization of the eluate gave 15 as a powder. The results are shown in Table 5 .
sulfonates (16 and Its trans Isomer)
General Procedure III: Removal of the Chloroacetyl Group: Sodium N-methyldithiocarbamate (129 mg, 1 mmol) was added to a stirred, cooled solution of 15 (1 mmol) in water (20 ml), and the mixture was stirred for 40 minutes at room temp. After further addition of sodium N-methyldithiocarbamate (65 mg, 0.5 mmol), the reaction mixture was stirred for 40 minutes, washed with ether and concentrated under reduced pressure. The concentrate was chromatographed on Amberlite XAD-2. Gradient elution with aq EtOH (0-10 %) and lyophilization of the eluate gave 16 as a powder. The results are shown in Table 6 . a All the compounds given the formula were analyzed for C , H and N; analytical results obtained for these elements were within +0.4 % of calculated values. b Not analyzed . 
